DILANTIN-125 SUSPENSION
BGP PHARMA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is DILANTIN-125 SUSPENSION discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that DILANTIN-125 SUSPENSION 125MG has been permanently discontinued (last updated December 19, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is DILANTIN-125 SUSPENSION not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
TARO-PHENYTOIN
TARO PHARMACEUTICALS INC
Other Products
DILANTIN
BGP PHARMA ULC
NOVO-PHENYTOIN CAP 100MG
NOVOPHARM LIMITED
DILANTIN INFATABS
BGP PHARMA ULC
DILANTIN INJ 50MG/ML
PARKE-DAVIS DIVISION, WARNER-LAMBERT CANADA INC.
PHENYTOIN SOIDUM INJECTION USP
PFIZER CANADA ULC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
00023450
Strength
125MG
Dosage Form
SUSPENSION
Route
ORAL
Active Ingredient
PHENYTOIN
Tier
Unrated
Last Updated
2025-12-19
Reason for Shortage
Business reasons
Past Reports for This Drug
DILANTIN-125 SUSPENSION has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BGP PHARMA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.